DocGo Inc.(DCGO)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings.

DocGo Inc. (DCGO) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores DCGO at 15.2/100 on a 32-signal composite quality model, placing it at rank #2,857 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (1.4) and balance sheet strength (2.4), which score below median versus the broader universe. Shareholder dilution risk is elevated at 23.7/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), DocGo Inc. reports quarterly revenue of $73.4M, net income of $-15.8M, free cash flow of $-9.6M. DCGO trades on the Nasdaq exchange and files with the SEC under CIK 1822359. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate DCGO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for DocGo Inc. directly from SEC EDGAR.